| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0515 | ||||
| Gene Name | ATP10A | ||||
| Protein Name | Probable phospholipid-transporting ATPase VA | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 6LCP_A Identity: 39.37% Minimized Score: -1235.898 kcal/mol Detail: Structure Info |
||||
| Synonyms | ATP10A; ATP10C; ATPVA; ATPVC; ATPase class V type 10A; Aminophospholipid translocase VA; KIAA0566; P4-ATPase flippase complex alpha subunit ATP10A | ||||
| DT Family | P-Type ATPase (P-ATPase) Superfamily ; | ||||
| Tissue Specificity | Widely expressed, with highest levels inkidney, followed by lung, brain, prostate, testis, ovary and smallintestine. | ||||
| Function | This transporter is a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules. | ||||
| Endogenous Substrate(s) | Phosphatidylserine | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.